Beijing Beilu Pharmaceutical Co (SZSE:300016) Other Operating Expense : ¥59.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Other Operating Expense?

Beijing Beilu Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥59.1 Mil.

Beijing Beilu Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-30.5 Mil) to Dec. 2023 (¥57.6 Mil) but then declined from Dec. 2023 (¥57.6 Mil) to Mar. 2024 (¥0.0 Mil).

Beijing Beilu Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥54.1 Mil) to Dec. 2022 (¥64.6 Mil) but then declined from Dec. 2022 (¥64.6 Mil) to Dec. 2023 (¥59.6 Mil).

Beijing Beilu Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Other Operating Expense Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

24.78

29.59

54.11

64.60

59.63

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															0.56	32.01	-30.48	57.55	0.05

Beijing Beilu Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥59.1 Mil.

Beijing Beilu Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co (SZSE:300016) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co (SZSE:300016) Headlines

No Headlines